MLTX FY 2024 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$143M

Net Income

-$119M

EPS (Diluted)

$-1.89

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$117M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$478M

Total Liabilities

$25M

Stockholders' Equity

$447M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$143M	-$54M	-164.4%
Net Income	-$119M	-$36M	-230.3%